Standout Papers

Discovery and Development of Janus Kinase (JAK) Inhibitors for Inflammatory Diseases 2014 2026 2018 2022 451
  1. Discovery and Development of Janus Kinase (JAK) Inhibitors for Inflammatory Diseases (2014)
    James D. Clark, Mark E. Flanagan et al. Journal of Medicinal Chemistry

Citation Impact

3 by Nobel laureates 24 from Science/Nature 56 standout
Sub-graph 1 of 20

Citing Papers

JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma
2024 StandoutScience
Interferon- γ and infectious diseases: Lessons and prospects
2024 StandoutScience
4 intermediate papers

Works of Mark E. Flanagan being referenced

Discovery and Development of Janus Kinase (JAK) Inhibitors for Inflammatory Diseases
2014 Standout

Author Peers

Author Molecular Biology Organic Chemistry RNMI Oncology Last Decade Papers Cites
Mark E. Flanagan 847 795 160 299 36 1.8k
J. Hauschild 2 2 25 946
S.L. Allen 226 7 3 2 10 641
Derek J. Linderman 736 32 58 603 12 1.6k
Leonora Wilkinson 47 34 2 36 1.5k
YN Shashidhara 13 1 7 127 23 306

All Works

Loading papers...

Rankless by CCL
2026